KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Staar Surgical (STAA) Change in Cash (2016 - 2026)

Staar Surgical (STAA) has disclosed Change in Cash for 17 consecutive years, with -$23.0 million as the latest value for Q1 2026.

  • For the quarter ending Q1 2026, Change in Cash fell 15.93% year-over-year to -$23.0 million, compared with a TTM value of $9.0 million through Jan 2026, up 123.13%, and an annual FY2026 reading of $9.0 million, up 123.13% over the prior year.
  • Change in Cash was -$23.0 million for Q1 2026 at Staar Surgical, down from $9.0 million in the prior quarter.
  • Across five years, Change in Cash topped out at $55.6 million in Q4 2023 and bottomed at -$73.2 million in Q3 2022.
  • Average Change in Cash over 5 years is -$2.9 million, with a median of -$1.2 million recorded in 2023.
  • The sharpest move saw Change in Cash plummeted 1335.9% in 2022, then soared 1075.06% in 2024.
  • Year by year, Change in Cash stood at -$42.8 million in 2022, then surged by 230.04% to $55.6 million in 2023, then tumbled by 135.69% to -$19.8 million in 2024, then surged by 145.47% to $9.0 million in 2025, then plummeted by 354.93% to -$23.0 million in 2026.
  • Business Quant data shows Change in Cash for STAA at -$23.0 million in Q1 2026, $9.0 million in Q3 2025, and -$6.0 million in Q2 2025.